Cargando…

Relation of red cell distribution width with HAS-BLED score in patients with non-valvular atrial fibrillation

BACKGROUND: Numerous researchers have shown that there is a close correlation between red cell distribution width (RDW) and cardiovascular disease such as heart failure, coronary heart disease, and atrial fibrillation. This study was designated to investigate the correlation between RDW and the Hype...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Hong-Li, Chen, Hao, Wang, Jing, Xie, Ling, Zheng, Kou-Long, Zhang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182543/ https://www.ncbi.nlm.nih.gov/pubmed/34164198 http://dx.doi.org/10.21037/jtd-21-567

Ejemplares similares

Use of simplified HAS‐BLED score in patients with atrial fibrillation receiving warfarin
por: Methavigul, Komsing, et al.
Publicado: (2019)

Revised HAS‐BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants
por: Methavigul, Komsing
Publicado: (2022)

Mortality Prediction of the CHA(2)DS(2)-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation
por: Morrone, Doralisa, et al.
Publicado: (2020)

HAS-BLED vs. ORBIT scores in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis
por: Liu, Xuyang, et al.
Publicado: (2023)

Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Gao, Xinxing, et al.
Publicado: (2021)

Increased levels of red cell distribution width is correlated with presence of left atrial stasis in patients with non-valvular atrial fibrillation
por: Kaya, Adnan, et al.
Publicado: (2017)

Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis
por: Wang, Cen, et al.
Publicado: (2017)

Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores
por: Proietti, Marco, et al.
Publicado: (2018)

Incremental Value of Genotype Bins over the HAS-BLED Score for the Prediction of Bleeding Risk in Warfarin-Treated Patients with Atrial Fibrillation
por: Liu, Jia, et al.
Publicado: (2021)

Assessment and comparison of CHADS2, CHA2DS2-VASc, and HAS-BLED scores in patients with atrial fibrillation in Saudi Arabia
por: Al-Turaiki, Abdulrahman M., et al.
Publicado: (2016)

Predictive value of red cell distribution width on left atrial thrombus or left atrial spontaneous echo contrast in patients with non-valvular atrial fibrillation
por: Zhan, Xian-Zhang, et al.
Publicado: (2018)

HAS-BLED Score for Prediction of Bleeding and Mortality After Transcatheter Aortic Valve Replacement
por: Albabtain, Monirah A., et al.
Publicado: (2023)

Relationship of the ORBIT and HAS-BLED scores with Killip class 3-4 in patients with ST-segment elevation myocardial infarction
por: Zhang, Qing, et al.
Publicado: (2019)

Association between red blood cell distribution width and non-valvular atrial fibrillation in hemodialysis patients: a single-center Chinese population study
por: Zhang, Tao, et al.
Publicado: (2022)

The Extended Utility of CHA(2)DS(2)VASc and HAS-BLED Scores in the Selection for Transcutaneous Left Atrial Appendage Closure
por: Streb, Witold, et al.
Publicado: (2020)

Comparison of HAS-BLED with other risk models for predicting the bleeding risk in anticoagulated patients with atrial fibrillation: A PRISMA-compliant article
por: Zeng, Junquan, et al.
Publicado: (2020)

Relationship between red blood cell distribution width levels and atrial fibrillation in hypertensive patients
por: ZHENG, Li-Hui, et al.
Publicado: (2020)

Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2020)

Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021)

Predictive Value of HAS-BLED Score Regarding Bleeding Events and Graft Survival following Renal Transplantation
por: Hau, Hans Michael, et al.
Publicado: (2022)

Red blood cell distribution width: A marker of anisocytosis potentially associated with atrial fibrillation
por: Lippi, Giuseppe, et al.
Publicado: (2019)

Performance of the HAS‐BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and Cancer: Data From the French National Hospital Discharge Database
por: Pastori, Daniele, et al.
Publicado: (2022)

Red cell distribution width and all-cause mortality in patients with atrial fibrillation: A cohort study
por: Saliba, Walid, et al.
Publicado: (2017)

Is the HAS-BLED score useful in predicting post-extraction bleeding in patients taking warfarin? A retrospective cohort study
por: Kataoka, Toshiyuki, et al.
Publicado: (2016)

Predictive Value of Red Blood Cell Distribution Width and Atrial Diameter in Paroxysmal Atrial Fibrillation: A Cross-Sectional Study
por: Lin, Guoli, et al.
Publicado: (2022)

Role of Red Cell Distribution Width in the Relationship between Clinical Outcomes and Anticoagulation Response in Patients with Atrial Fibrillation
por: Lee, Ki Hong, et al.
Publicado: (2018)

Red Cell Distribution Width as a Novel Marker for Different Types of Atrial Fibrillation in Low and High Altitude
por: Han, Kaiyue, et al.
Publicado: (2019)

Increased red blood cell distribution width might predict left ventricular hypertrophy in patients with atrial fibrillation
por: Yao, Hui-Ming, et al.
Publicado: (2020)

Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease
por: Chen, Jian-Qin, et al.
Publicado: (2023)

Stroke in hemodialysis patients and its association with CHA(2)DS(2)-VASC and HAS-BLED scores: a retrospective study
por: Sab, Marc, et al.
Publicado: (2022)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
por: Samaras, Athanasios, et al.
Publicado: (2021)

Relationship between the Hemoglobin-to-Red Cell Distribution Width Ratio and All-Cause Mortality in Septic Patients with Atrial Fibrillation: Based on Propensity Score Matching Method
por: Wang, Junhong, et al.
Publicado: (2022)

Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
por: Liu, Yaowu, et al.
Publicado: (2021)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

Stroke Prevention in Atrial Fibrillation and Valvular Heart Disease
por: Ahmad, Saad, et al.
Publicado: (2016)

Red cell distribution width and its polygenic score in relation to mortality and cardiometabolic outcomes
por: Pan, Jingxue, et al.
Publicado: (2023)

Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS‐BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment
por: Brown, Joshua D., et al.
Publicado: (2018)

Can CHA(2)DS(2)-VASc and HAS–BLED Foresee the Presence of Cerebral Microbleeds, Lacunar and Non-Lacunar Infarcts in Elderly Patients With Atrial Fibrillation? Data From Strat–AF Study
por: Bianconi, Elisa, et al.
Publicado: (2022)

Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya
por: Temu, Tecla M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gf70kounuc30g7ivs3l5cnpjso